Platelets in Atherothrombosis

Slides:



Advertisements
Similar presentations
Coagulation Bruno Sopko.
Advertisements

An Overview of Hemostasis
Hemostasis & Thrombosis: Platelet Disorders Beth A. Bouchard BIOC 212: Biochemistry of Human Disease Spring 2005.
Haemostasis and NovoSeven®
PLATELETS (PLT) Thrombocytes. PLATELETS (PLT) Thrombocytes.
Coagulation (the basics) and recombinant Factor VIIa Mechanism of Action Jerrold H. Levy, MD Emory University School of Medicine and Emory Healthcare Atlanta,
REVIEW OF HAEMOSTASIS Dr J Jordaan Dept Cardiothoracic surgery and Critical care University of the Free State Bloemfontein EACTS/ Hannes Meyer symposium.
Prostaglandins and Related Compounds 1Dr. Nikhat Siddiqi.
Blood coagulation involves a biological amplification system in which relatively few initiation substances sequentially activate by proteolysis a cascade.
Blood S-J Tsai Department of Physiology. Composition Composed of cells (erythrocytes, leukocytes, and platelets) and plasma (the liquid in which the cells.
Damaged Blood Vessels. On vessel injury
Coagulation Cascade Ahmad Shihada Silmi Msc,FIBMS IUG Faculty of Science Medical Technology Dept.
Tabuk University Faculty of Applied Medical Sciences Department Of Medical Lab. Technology 3 rd Year – Level 5 – AY
Associate Professor of Physiology,
Implant of a Medical Device and the Wound Healing Process.
Hemostasis Constriction of vessel Aggregation of platelets
Nerves Smooth muscle Endothelium Platelets White cells eg neutrophils Red cells.
Objectives At the end of this lecture student should be able to: 1.Recognize different stages of hemostasis 2.Describe formation and development.
Prostaglandins & Related compounds. EICOSANOIDS Compounds that originate from polyunstaurated fatty acids with 20 carbons Prostaglandins (PG) Prostaglandins.
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Principles of Pharmacology The Pathophysiologic Basis of Drug Therapy.
Coagulation and fibrinolysis
Hemodynamics 2.
My Treatment Approach to Hairy Cell Leukemia Rahul R. Naik, MD, Alan Saven, MD Mayo Clinic Proceedings Volume 87, Issue 1, Pages (January 2012) DOI:
Date of download: 7/9/2016 From: Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies for Acute Coronary Syndrome: A Narrative Review Ann.
Platelets (Thrombocytes)
Principles of Blood Coagulation
HAEMOSTASIS AND THROMBOSIS Regulation of coagulation
Prostaglandins and Related Compounds
Inflammation lecture 4 Dr Heyam Awad FRCPath.
A. Formation of the Platelet Plug
Activation of the Hemostatic System During Cardiopulmonary Bypass
Activation of the Hemostatic System During Cardiopulmonary Bypass
General Principles of Hemostasis Kristine Krafts, M.D.
Aspirin and Clopidogrel Resistance
Drugs Used in Coagulation Disorders
What is a Blood Clot? 9/18/2018 MEDC 604 Anti-coagulants.
Hemodynamic disorders (1 of 3)
and anti-thrombotic pharmocology Tom Williams
Coagulation and Anti-coagulation
Nat. Rev. Nephrol. doi: /nrneph
Anti-Coagulants Physical Process of Clotting
Implant of a Medical Device and the Wound Healing Process.
Review of haemostasis EACTS/ Hannes Meyer symposium 2012 Dr J Jordaan
Role of microparticles in sepsis
How to Interpret and Pursue an Abnormal Prothrombin Time, Activated Partial Thromboplastin Time, and Bleeding Time in Adults  Arif H. Kamal, MD, Ayalew.
Chemical Mediators Dr Shoaib Raza.
PMNs deliver first aid to clot
William L. Lanier, MD  Mayo Clinic Proceedings 
Figure 1 Mechanism of thrombus formation during ST-segment
Pharmacologic inhibition of nitric oxide synthases and cyclooxygenases enhances intimal hyperplasia in balloon-injured rat carotid arteries  Jens W Fischer,
Anti-Coagulants Physical Process of Clotting
Coagulation and innate immune responses: can we view them separately?
Volume 55, Issue 6, Pages (December 2011)
Aspirin and Clopidogrel Resistance
Gregg W. Stone, MD, Herbert D. Aronow, MD, MPH  Mayo Clinic Proceedings 
Paul A. Gurbel, and Udaya S. Tantry JCHF 2014;2:1-14
Volume 141, Issue 2, Pages e89S-e119S (February 2012)
Thrombin During Cardiopulmonary Bypass
General Principles of Hemostasis Kristine Krafts, M.D.
Peter Celec, Yoshikazu Yonemitsu  Pathophysiology 
Effects of Statins on Renal Function
Thrombosis and Inflammatory Bowel Disease
Volume 81, Issue 12, Pages (June 2012)
Refurbishing Mayo Clinic Proceedings:
The “Aspirin” of the New Millennium: Cyclooxygenase-2 Inhibitors
Hemostasis Hemostasis depends on the integrity of Blood vessels
Section B: Science update
Volume 141, Issue 2, Pages e89S-e119S (February 2012)
Mayo Clinic Proceedings 2012: “A New Era in Journal Stewardship”
Presentation transcript:

Platelets in Atherothrombosis David A. Vorchheimer, MD, Richard Becker, MD  Mayo Clinic Proceedings  Volume 81, Issue 1, Pages 59-68 (January 2006) DOI: 10.4065/81.1.59 Copyright © 2006 Mayo Foundation for Medical Education and Research Terms and Conditions

FIGURE 1 Platelet adhesion and activation. From Antiplatelet Therapy in Clinical Practice,7 with permission. Mayo Clinic Proceedings 2006 81, 59-68DOI: (10.4065/81.1.59) Copyright © 2006 Mayo Foundation for Medical Education and Research Terms and Conditions

FIGURE 2 Platelet shape changes and aggregation. From Arterioscler Thromb Vasc Biol,9 with permission from Lippincott Williams & Wilkins. Mayo Clinic Proceedings 2006 81, 59-68DOI: (10.4065/81.1.59) Copyright © 2006 Mayo Foundation for Medical Education and Research Terms and Conditions

FIGURE 3 Traditional cascade model of coagulation. The intrinsic system represents the clotting factors in the circulating blood. The extrinsic system represents tissue factor in complex with factor VII. HK = high-molecular-weight kininogen; PK = prekallikrein; TF = tissue factor. From Anesthesiology,10 with permission from Lippincott Williams & Wilkins. Mayo Clinic Proceedings 2006 81, 59-68DOI: (10.4065/81.1.59) Copyright © 2006 Mayo Foundation for Medical Education and Research Terms and Conditions

FIGURE 4 Cell-based model of coagulation. Activated cofactors Va and VIIIa occupy sites in the activated platelet before binding of the respective enzymes, factors Xa and IXa. Factor Xa on the activated platelets is recruited from circulating factor X. The burst of thrombin generation takes place on the platelet surface. Thrombin generation can be boosted by further activation of factor IX by factor XIa. The burst of thrombin is sufficient to convert fibrinogen to fibrin. TF = tissue factor. From Anesthesiology,10 with permission from Lippincott Williams & Wilkins. Mayo Clinic Proceedings 2006 81, 59-68DOI: (10.4065/81.1.59) Copyright © 2006 Mayo Foundation for Medical Education and Research Terms and Conditions

FIGURE 5 Rolling of polymorphonuclear leukocytes (PMN) on adherent, activated platelets is mediated via interactions between P-selectin and P-selectin glycoprotein 1 (PSGL-1). From J Thromb Haemost,22 with permission from Blackwell Publishing. Mayo Clinic Proceedings 2006 81, 59-68DOI: (10.4065/81.1.59) Copyright © 2006 Mayo Foundation for Medical Education and Research Terms and Conditions

FIGURE 6 Interactions between platelets (PLT) and endothelial cells (EC) mediated by arachidonic acid (AA) metabolites. Activators of each cell type induce phospholipase A2 (PLA2)-mediated hydrolysis of free AA from membrane phospholipid (PL) pools. The AA is converted by cyclooxygenase (COX) to the prostaglandin endoperoxides, PGG2 and PGH2. Endoperoxides are metabolized to thromboxane A2 (TXA2) by thromboxane synthase (TxS) in platelets and to PGI2 by prostacyclin synthase (PS) in endothelial cells. The TXA2 binds to platelet receptors to stimulate platelet activation; PGI2 binds to separate platelet receptors to inhibit platelet activation. From Am J Med,44 with permission from Excerpta Medica, Inc. Mayo Clinic Proceedings 2006 81, 59-68DOI: (10.4065/81.1.59) Copyright © 2006 Mayo Foundation for Medical Education and Research Terms and Conditions